Foghorn Therapeutics Inc. Common Stock
Symbol: FHTX (NASDAQ)
4.05
▲ (3.72%) 0.145
Company Description:
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Key Stats
- Today's Open: $3.99
- Today's High: $4.197
- Today's Low: $3.85
- Today's Volume: 234.08K
- Yesterday Close: $3.9
- Yesterday High: $4.14
- Yesterday Low: $3.89
- Yesterday Volume: 153.62K
- Last Min Volume: 1
- Last Min High: $4.045
- Last Min Low: $4.045
- Last Min VWAP: $4.045
Company Profile
- Name: Foghorn Therapeutics Inc. Common Stock
- Website: https://www.foghorntx.com
- Listed Date: 2020-10-23
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001822462
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $220.47M
- Round Lot: 100
- Outstanding Shares: 56.53M
- Asset Type: CS
RECENT FILINGS FOR FHTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-05 | ARS | View |
| 2025-05-05 | DEFA14A | View |
| 2025-05-05 | DEF 14A | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 3 | View |
Latest News on FHTX